25 October 2021 in Pharmacy & Pharmacology
the aim. Focused on optimizing the assortment portfolio of pharmacy organizations and improving the process of drug supply to end-consumers, the aim of the study was to analyze the regional pharmaceutical market for antihistamines.Materials and methods. In the study, the following methods were used: a content analysis of regulatory documents; a documentary observation method of the volume of antihistamines sales; a sociological survey method. The objects of the study were accounting registers in 32 pharmacy organizations for 2020, as well as the sociological survey results of 174 respondents – consumers of antihistamines.Results. The classification analysis of 38 international non-proprietary trade names of antihistamines, represented by 187 names of drugs, revealed the prevalence of the first-generation drugs (63%). On the Russian pharmaceutical market, there were also 55% of foreign production drugs. At the regional level, there are 66 types of drugs in circulation, 50% of which are second-generation ones. The cost analysis showed rather a wide rage of the pricing proposal and the economic availability of antihistamines for patients. The sociological survey revealed the fact that 46% of the consumers were ready to pay for the necessary drugs in the price range “over 100 and up to 500 rubles” (over $ 1.38 and up to $ 6.88) for one conventional package. A medical-demographic profile of the antihistamines consumer at the regional level has been made up, and guidelines for pharmaceutical specialists on managing the assortment portfolio of pharmaceutical organizations have been developed.Conclusion. As a result of the study, the following facts have been established: the seasonal peaks in the antihistamines consumption; a gradual renewal of the pharmacies assortment portfolio due to the increased consumption of the second and third generation antihistamines. The medical and demographic profile of the consumer should be taken into consideration when planning a drug provision for the patients with allergic pathologies, and it is connected with the growth in pharmacies profits due to the sale of drugs in the range from 100 to 500 rubles (from $ 1.38 to $ 6.88). The methodical recommendations have been brought to the attention of the management of regional pharmacy organizations.
6 August 2025 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Background. Studies on the pharmaceutical provision of neovascular age-related macular degeneration with angiogenesis inhibitors in the Russian Federation have repeatedly indicated a mismatch between the level of consumption and the actual need for these drugs. This highlights the importance of further research on the issue through marketing analysis.Objective: To conduct a marketing analysis of the market for angiogenesis inhibitors used in the treatment of neovascular age-related macular degeneration, including assessment of the product range, price dynamics, demand and consumption, as well as index analysis for the period of 2018–2024.Material and methods. The study was based on open data on the procurement of angiogenesis inhibitors in the public sector, price characteristics, and information on consumption with compulsory health insurance system (24-hour and day hospitals as well as high-tech medical care). The scientific and methodological framework of the study included methods for analyzing the sales of drugs from the group of angiogenesis inhibitors registered for medical use in the Russian Federation, as well as methodological tools for calculating a series of chain indices (including the weighted average price index, price index, structural shift index, index of changes in sales volumes in physical terms, modified Herfindahl–Hirschman index). Methods for analyzing the life cycle of the drugs and comparing the volumes of their procurement and consumption volumes were also used.Results. During the study period, there was a noticeable increase in the demand for and consumption of angiogenesis inhibitors: procurement volumes in physical terms grew 2.53-fold, and in monetary terms 1.62-fold. The positive dynamics of the market for the studied group of drugs were accompanied by an increase in weighted average prices and a growing share of more expensive drugs in the procurement structure. Between 2021 and 2023, uneven growth was observed in procurement volumes in physical terms and in the number of hospitalizations involving the use of these drugs. The ratio of hospitalization volumes to procurement volumes during this period was 1.21, 1.46, and 1.47, respectively, indicating that a single vial of the drug was used for multiple patients. The disproportion between procurement volumes and the number of hospitalizations points to a significant additional potential demand for angiogenesis inhibitors. The current market conditions can be characterized as attractive for manufacturers and suppliers.Conclusion. It was established that the market for angiogenesis inhibitors was characterized by both qualitative and quantitative growth, with sustained positive development dynamics. The identified features of procurement and consumption indicate the need for further research aimed at developing optimal solutions for ensuring the pharmaceutical provision of angiogenesis inhibitors to consumers in the required range and sufficient volumes.
30 March 2023 in "Medical & Pharmaceutical Journal "Pulse"
24 July 2022 in Pharmacy & Pharmacology
The aim of the article is the structure and content specification of the subject area professional term “drug supply” in order to deepen and concretize the conceptual apparatus in the field of the pharmaceutical activity.Materials and methods. The review presents the analysis of 389 titles of scientific pharmaceutical publications for the periods of 1995–1998 and 2010–2019. The selection of publications was carried out by the random sampling based on the phrases: «drug provision», «medical care», «provision of medicines», «pharmaceutical care», «medicinal services», «drug supply» and their English-language counterparts in Russian and foreign electronic information sources. A methodological base of the study was a cluster analysis of the subject area concept of “drug supply” according to the methodology proposed by E.A. Korzhavykh and I.V. Voronovich. In this study, a cluster was interpreted as a set of publications in which a certain pair of terms was simultaneously cited with a preset frequency of co-citation.Results. When analyzing the publications, two clusters of the “drug supply” concept were formed for the time periods indicated above. The comparison of the clusters showed an increase in the activity of the scientific research to expand the structure and content of the subject area of the “drug supply” concept. For the modern cluster, 124 co – cited pairs of lexical units were selected. They were grouped into 9 hierarchy levels according to the strength of relationship between an interval of 10 units and mentioning frequencies of the “drug supply” term. At the final stage, a graphical model of the “drug supply” concept cluster was formed. It was established that the lexical units included from the first to the fifth level, are the cluster nucleus of the “drug supply” concept as the most stable part of the lexical array, which it is advisable to rely on when developing a definition for the concept under study.Conclusion. Thus, the subject field of the “drug supply” concept is characterized by the scientific research, reflecting the socio-economic significance of the objects under study in the field of pharmaceutical activities, and its content is characterized by a high level of pharmaceutical knowledge which describes the most stable elements that make it possible to formulate an adequate definition of the “drug supply” definition.
30 June 2021 in "Medical & Pharmaceutical Journal "Pulse"
Improving the availability of medical and medicinal care is the most important task of all levels of government and especially relevant in the context of modernization of the health system. The purpose of the work was to analyze the peculiarities of the functioning of the Drug Provision System of the Rural Population of the Republic of Adygea to identify reserves for its development and substantiate directions for further improvement, taking into account regional conditions. It was established that in the Republic of Adygea out of 160 units of medical organizations, the right of retail trade in drugs, 112 medical and obstetric items that have licenses for pharmaceutical activities are used by drug trading. A feature of the implementation of pharmaceutical activities in rural areas is the absence in most places of modern transport highways, which creates logistics problems and significantly complicates the regular delivery of drugs to the population. Among the positive points, the appearance of an additional way of delivering drugs to the feldsher-obstetric items located in hard-to-reach (mountainous) areas implemented in the federal population to ensure the necessary drugs is noted. The inclusion of pharmacies of partners in the system of ensuring the population did not require additional agreements and expenditures on their services, since this function does not carry additional costs, but at the same time increases their image. It has been established that over the past 2 years, the quality of drugs in the countryside residents decreased significantly. In the region, the number of current pharmaceutical activities has decreased by 21%, the number of operating paramedic-obstetric items has also decreased by 18%, and the number of pharmacies of the program has decreased by 2.8 times. Currently, unresolved problems of the organizational nature came to the fore, among which: the absence of working capital organizations for the acquisition of drugs, in the presence of extrabudgetary funds received from the implementation of paid medical services; insufficient legal training of individual officials of medical organizations in state procurement issues; the absence from the overwhelming number of retail trade licenses for transportation of goods of pharmacy assortment and others. The identified problems are based on the basis of the work plan of health authorities, pharmaceutical activities, medical and pharmaceutical organizations of the Republic of Adygea to improve the forms and working methods for the provision of agricultural drugs.
30 April 2023 in "Medical & Pharmaceutical Journal "Pulse"
KAKorzhavykh Eleonora Alexandrovna
Korzhavykh Eleonora Alexandrovna